Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus

Clinical and Experimental Immunology

Volumn 177, Issue 1, 2014, Pages 24-29

  Udayappan, S D ^a   Hartstra, A V ^a   Dallinga Thie, G M ^a   Nieuwdorp, M ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Diabetes; Host pathogen interactions; Lipopolysaccharide

Indexed keywords

BILE ACID; BUTYRIC ACID; GLUCOSE; LIPOPOLYSACCHARIDE; SHORT CHAIN FATTY ACID;

ARTICLE; BACTERIAL STRAIN; CONSERVATIVE TREATMENT; DISEASE COURSE; DONOR; ENDOTOXEMIA; FAECAL TRANSPLANTATION; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; LIPID METABOLISM; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRANSPLANTATION;

DIABETES; HOST-PATHOGEN INTERACTIONS; LIPOPOLYSACCHARIDE;

ANIMALS; BUTYRATES; DIABETES MELLITUS, TYPE 2; FECES; HUMANS; INSULIN RESISTANCE; INTESTINES; LIPID METABOLISM; MICROBIOTA; TRANSPLANTATION;

EID: 84904241350     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12293     Document Type: Article

References (50)

1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007; 356:213-215.
2. Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology 2009; 136:1476-1483.
3. DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc 2008; 83:460-469.
4. Duncan SH, Lobley GE, Holtrop G etal. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond) 2008; 32:1720-1724.
5. Cani PD, Amar J, Iglesias MA etal. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56:1761-1772.
6. Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013; 145:946-953.
7. Vrieze A, Van Nood E, Holleman F etal. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in subjects with metabolic syndrome. Gastroenterology 2012; 143:913-916. http://dx.doi.org/10.1053/j.gastro.2012.06.031 (20 June 2012).
8. Jiménez E, Marín ML, Martín R etal. Is meconium from healthy newborns actually sterile? Res Microbiol 2008; 159:187-193.
9. Dominguez-Bello MG, Costello EK, Contreras M etal. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107:11971-11975.
10. Blustein J, Attina T, Liu M etal. Association of caesarean delivery with child adiposity from age 6 weeks to 15 years. Int J Obes (Lond) 2013; 37:900-906.
11. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond) 2013; 37:16-23.
12. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLOS Biol 2007; 39:e177.
13. Newburg DS. Neonatal protection by innate immune system of human milk consisting of oligosaccharides and glycans. J Anim Sci 2009; 39:26-34.
14. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-1023.
15. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-230.
16. Rautava S, Walker WA. Commensal bacteria and epithelial cross talk in the developing intestine. Curr Gastroenterol Rep 2007; 9:385-392.
17. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159:1739-1745.
18. Turnbaugh PJ, Ley RE, Mahowald MA etal. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-1031.
19. Le Chatelier E, Nielsen T, Qin J etal. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-546.
20. Wu GD, Chen J, Hoffmann C etal. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334:105-108.
21. David LA, Maurice CF, Carmody RN etal. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2013; 505:559-563.
22. Dougherty RM, Galli C, Ferro-Luzzi A, Iacono JM. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am J Clin Nutr 1987; 45:443-455.
23. Backhed F, Ding H, Wang T etal. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101:15718-15723.
24. Turnbaugh PJ, Hamady M, Yatsunenko T etal. A core gut microbiome in obese and lean twins. Nature 2009; 457:480-484.
25. de Vos WM, Nieuwdorp M. Genomics: a gut prediction. Nature 2013; 498:48-49.
26. Qin J, Li Y, Cai Z etal. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490:55-60.
27. Karlsson FH, Tremaroli V, Nookaew I etal. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013; 498:99-103.
28. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012; 18:363-374.
29. Amar J, Serino M, Lange C etal., DESIR Study Group. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 2011; 54:3055-3061.
30. Caesar R, Reigstad CS, Bäckhed HK etal. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 2012; 61:1701-1707.
31. Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 2009; 50:90-97.
32. Schwiertz A, Taras D, Schäfer K etal. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18:190-195.
33. Donohoe DR, Garge N, Zhang X etal. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011; 13:517-526.
34. Gao Z, Yin J, Zhang J etal. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009; 58:1509-1517.
35. Maslowski KM, Vieira AT, Ng A etal. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461:1282-1286.
36. Johnson MT, Stinchcombe JR. An emerging synthesis between community ecology and evolutionary biology. Trends Ecol Evol 2007; 22:250-257.
37. Tazoe H, Otomo Y, Kaji I, Tanaka R, Karaki SI, Kuwahara A. Roles of short chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 2008; 59 (Suppl. 2):251-262.
38. Samuel BS, Shaito A, Motoike T etal. Effects of the gut microbiota on host adiposity are modulated by the short chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 2008; 105:16767-16772.
39. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003; 133 (Suppl. 7):2485S-2493.
40. Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 2008; 7:678-693.
41. Wostmann BS. Intestinal bile acids and cholesterol absorption in the germfree rat. J Nutr 1973; 103:982-990.
42. Madsen D, Beaver M, Chang L, Bruckner-Kardoss E, Wostmann B. Analysis of bile acids in conventional and germfree rats. J Lipid Res 1976; 17:107-111.
43. Miyata M, Takamatsu Y, Kuribayashi H, Yamazoe Y. Administration of ampicillin elevates hepatic primary bile acid synthesis through suppression of ileal fibroblast growth factor 15 expression. J Pharmacol Exp Ther 2009; 31:1079-1085.
44. Vrieze A, Out C, Fuentes S etal. Vancomycin decreases insulin sensitivity and is associated with alterations in intestinal microbiota and bile acid composition in obese subjects with metabolic syndrome. J Hepatol 2013; 60:824-831. P. ii: S0168-8278(13)00837-4.
45. Weingarden AR, Chen C, Bobr A etal. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 2013; 306:G310-319.
46. Thomas C, Gioiello A, Noriega L etal. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10:167-177.
47. Prawitt J, Abdelkarim M, Stroeve JH etal. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 2011; 60:1861-1871.
48. Ridaura VK, Faith JJ, Rey FE etal. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341:1241214.
49. Song SJ, Lauber C, Costello EK etal. Cohabiting family members share microbiota with one another and with their dogs. eLife 2013; 2:e00458.
50. Olle B. Medicines from microbiota. Nat Biotechnol 2013; 31:309-315.